Search Prime Grants

U24HG010862

Cooperative Agreement

Overview

Grant Description
Pharmacogenomics clinical annotation tool (PharmCAT)
Funding Goals
NHGRI SUPPORTS THE DEVELOPMENT OF RESOURCES AND TECHNOLOGIES THAT WILL ACCELERATE GENOME RESEARCH AND ITS APPLICATION TO HUMAN HEALTH AND GENOMIC MEDICINE. A CRITICAL PART OF THE NHGRI MISSION CONTINUES TO BE THE STUDY OF THE ETHICAL, LEGAL AND SOCIAL IMPLICATIONS (ELSI) OF GENOME RESEARCH. NHGRI ALSO SUPPORTS THE TRAINING AND CAREER DEVELOPMENT OF INVESTIGATORS AND THE DISSEMINATION OF GENOME INFORMATION TO THE PUBLIC AND TO HEALTH PROFESSIONALS. THE SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM IS USED TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. THE SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM IS USED TO FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Place of Performance
Philadelphia, Pennsylvania 191046145 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the End Date has been extended from 05/31/23 to 05/31/24 and the total obligations have increased 188% from $560,000 to $1,610,071.
Trustees Of The University Of Pennsylvania was awarded Pharmacogenomics Clinical Annotation Tool (PharmCAT) Cooperative Agreement U24HG010862 worth $1,610,071 from National Human Genome Research Institute in August 2020 with work to be completed primarily in Philadelphia Pennsylvania United States. The grant has a duration of 3 years 9 months and was awarded through assistance program 93.172 Human Genome Research. The Cooperative Agreement was awarded through grant opportunity Genomic Community Resources (U24).

Status
(Complete)

Last Modified 10/4/24

Period of Performance
8/7/20
Start Date
5/31/24
End Date
100% Complete

Funding Split
$1.6M
Federal Obligation
$0.0
Non-Federal Obligation
$1.6M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U24HG010862

Subgrant Awards

Disclosed subgrants for U24HG010862

Transaction History

Modifications to U24HG010862

Additional Detail

Award ID FAIN
U24HG010862
SAI Number
U24HG010862-2435217418
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N400 NIH NATIONAL HUMAN GENOME RESEARCH INSTITUTE
Funding Office
75N400 NIH NATIONAL HUMAN GENOME RESEARCH INSTITUTE
Awardee UEI
GM1XX56LEP58
Awardee CAGE
7G665
Performance District
PA-03
Senators
Robert Casey
John Fetterman

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Human Genome Research Institute, National Institutes of Health, Health and Human Services (075-0891) Health research and training Grants, subsidies, and contributions (41.0) $1,120,000 100%
Modified: 10/4/24